Portage Biotech Net Income

The latest net income for PRTG is $-6.8M as of March 2025. That compares with $-75M in the prior-year period — up 91.0% year over year. That is below the Energy sector average of $51B. Investors often review this figure alongside Portage Biotech's historical trend and sector peers before judging valuation or financial health.

Over the past year, PRTG's net income moved from $-75M to $-6.8M — a 91.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Portage Biotech's operating scale or balance-sheet position.

Against Energy companies, PRTG currently prints $-6.8M for net income, while the sector average sits near $51B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Portage Biotech's growth, margins, and balance sheet.

A net income figure of $-6.8M for PRTG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Energy average is about $51B. Explore the charts below for those layers of context.

After noting PRTG's net income ($-6.8M), review year-over-year change from $-75M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.